DaVita Clinical Research Celebrates International Clinical Trials Day

MINNEAPOLIS, May 19, 2017 /PRNewswire/ -- DaVita Clinical Research (DCR), a specialty contract research organization with services spanning the full spectrum of drug and device development, is celebrating International Clinical Trials Day by increasing awareness of the importance of clinical research and recognizing the contributions that trial participants and the health care community have made in advancing health care through research.

"International Clinical Trials Day presents an opportunity to acknowledge the tremendous effect that more than 270 years of clinical trials have had on the advancement of quality in health care," said Francesca Tentori, medical director of outcomes research and member of the Office of the Chief Medical Officer. "DaVita Clinical Research provides the data and support that physicians need to continue to drive patient-centered care."

DaVita Clinical Research is working to spread awareness on the value of clinical research by sharing educational infographics and videos, and by visiting clinics across the United States. Locations include Las Vegas and multiple cities in California. Visit DaVitaClinicalResearch.com/ResearchMatters/ for more information.

With an extensive international network of more than 200 physician researchers and more than 250 research sites, DaVita Clinical Research has published more than 600 scientific abstracts and 295 scientific manuscripts since 2006. It has also supported DaVita Kidney Care with continuing to surpass national averages in clinical outcomes.

To learn more about DaVita Clinical Research, visit DaVitaClinicalResearch.com or follow along using the hashtag #iSupportResearch on Instagram and Twitter.

DaVita Clinical Research and DCR are registered trademarks of DaVita Inc.

About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment and completion of retrospective, prospective and pragmatic clinical trials. DCR's scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR's Early Clinical Research unit (Phase I-IIa) and Late Phase Clinical Research (Phase IIb through post-marketing) network of physicians and investigative sites, and Real-World Healthcare Data  are focused on providing world-class research in both complex/specialty populations and therapeutic areas and especially in CKD and ESRD populations. To learn more about DCR, visit DaVitaClinicalResearch.com.

About DaVita Inc.
DaVita Inc. (NYSE: DVA), a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of March 31, 2017, DaVita Kidney Care operated or provided administrative services at 2,382 outpatient dialysis centers located in the United States serving approximately 189,400 patients. The company also operated 162 outpatient dialysis centers located in 11 countries outside the United States. DaVita Medical Group manages and operates medical groups and affiliated physician California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of December 31, 2016, DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVita.com/about. 

Contact Information
Media:
Lindsey Robinson
720-925-3079    
[e-mail]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/davita-clinical-research-celebrates-international-clinical-trials-day-300460492.html

SOURCE DaVita Clinical Research

Copyright 2017 PR Newswire